Analysis Of Income And Expense [Abstract]

Biotage - Filing #689619

Concept 2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue
1 566 SEK
1 232 SEK
Material income and expense [abstract]
Research and development expense
109,000,000 SEK
91,000,000 SEK
Finance income (cost)
21,000,000 SEK
2,000,000 SEK
Selling, general and administrative expense [abstract]
Selling expense
3 79 SEK
28 7 SEK
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
SEK
SEK
352,000,000 SEK
268,000,000 SEK
84,000,000 SEK
SEK
SEK
SEK
67,000,000 SEK
SEK
272,000,000 SEK
205,000,000 SEK
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent
352,000,000 SEK
27 2 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.